Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Revenue

Samrat Pharmachem had revenue of 788.70M INR in the quarter ending September 30, 2025, with 12.40% growth. This brings the company's revenue in the last twelve months to 2.89B, down -2.02% year-over-year. In the fiscal year ending March 31, 2025, Samrat Pharmachem had annual revenue of 2.86B with 1.52% growth.

• Revenue (ttm): 2.89B
• Revenue Growth: -2.02%
• P/S Ratio: 0.22
• Revenue / Employee: 103.38M
• Employees: 28
• Market Cap: 649.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.86B	42.90M	1.52%
Mar 31, 2024	2.82B	-291.06M	-9.37%
Mar 31, 2023	3.11B	888.86M	40.06%
Mar 31, 2022	2.22B	426.92M	23.83%
Mar 31, 2021	1.79B	416.39M	30.28%